SLC6A3 and Parkinson disease: Dementia with Lewy bodies (DLB) and Parkinsonʼs disease (PD) are nigrostriatal dopaminergic neurodegenerative diseases (dNDDs) characterized by reduced expression of dopamine transporter (DAT) in striatal dopamine nerve terminals [1–3].